XML 105 R86.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplemental Data - Condensed Consolidating Statements of Income (Detail) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues $ 2,718,403,000 $ 2,494,609,000 $ 5,309,477,000 $ 4,917,395,000
Less: Provision for uncollectible accounts (49,406,000) (109,600,000) (23,861,000) (216,658,000)
Net dialysis and related lab patient service revenues 2,668,997,000 2,385,009,000 5,285,616,000 4,700,737,000
Other revenues 217,956,000 314,390,000 450,781,000 629,913,000
Total revenues 2,886,953,000 2,699,399,000 5,736,397,000 5,330,650,000
Operating expenses 2,448,761,000 2,308,203,000 4,887,519,000 4,063,526,000
Operating income 438,192,000 391,196,000 848,878,000 1,267,124,000
Debt expense, including refinancing charges     (233,208,000)  
Other income 1,994,000 4,798,000 6,576,000 8,784,000
Income tax expense 83,868,000 101,915,000 154,605,000 383,580,000
Net income from continuing operations 236,626,000 186,145,000 467,641,000 679,997,000
Net income (loss) from discontinued operations, net of tax 69,696,000 (24,520,000) 63,910,000 (18,087,000)
Net income 306,322,000 161,625,000 531,551,000 661,910,000
Less: Net income attributable to noncontrolling interests (39,046,000) (34,624,000) (85,589,000) (87,212,000)
Net income attributable to DaVita Inc. $ 267,276,000 $ 127,001,000 445,962,000 $ 574,698,000
Physician Groups        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues     0  
Less: Provision for uncollectible accounts     0  
Net dialysis and related lab patient service revenues     0  
Other revenues     0  
Total revenues     0  
Operating expenses     0  
Operating income     0  
Debt expense, including refinancing charges     0  
Other income     0  
Income tax expense     0  
Net income from continuing operations     0  
Net income (loss) from discontinued operations, net of tax     16,466,000  
Net income     16,466,000  
Less: Net income attributable to noncontrolling interests     (8,544,000)  
Net income attributable to DaVita Inc.     7,922,000  
Unrestricted Subsidiaries        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues     0  
Less: Provision for uncollectible accounts     0  
Net dialysis and related lab patient service revenues     0  
Other revenues     0  
Total revenues     0  
Operating expenses     0  
Operating income     0  
Debt expense, including refinancing charges     0  
Other income     0  
Income tax expense     0  
Net income from continuing operations     0  
Net income (loss) from discontinued operations, net of tax     323,000  
Net income     323,000  
Less: Net income attributable to noncontrolling interests     0  
Net income attributable to DaVita Inc.     323,000  
Company and Restricted Subsidiaries        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues     5,309,477,000  
Less: Provision for uncollectible accounts     (23,861,000)  
Net dialysis and related lab patient service revenues     5,285,616,000  
Other revenues     450,781,000  
Total revenues     5,736,397,000  
Operating expenses     4,887,519,000  
Operating income     848,878,000  
Debt expense, including refinancing charges     (233,208,000)  
Other income     6,576,000  
Income tax expense     154,605,000  
Net income from continuing operations     467,641,000  
Net income (loss) from discontinued operations, net of tax     47,121,000  
Net income     514,762,000  
Less: Net income attributable to noncontrolling interests     (77,045,000)  
Net income attributable to DaVita Inc.     $ 437,717,000